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The presence of acetone in human breath of diabetic subjects has 
been known for many years. Breath acetone content of normal human beings 
was first determined as early as 1920, and it was the first of the three 
ketone bodies (acetoacetate, S-hydroxybutyrate, acetone) to be identified 
in uncontrolled diabetics (Sulway and Trotter, 1971). Ketone bodies are 
found in the blood of normal human beings, but their levels are increased 
under carbohydrate deficiency, or high fat diet, or severe exercise in 
the postabsorptive state (Harper, 1973; Lehninger, 1977). When carbohy-
drate is deficient in the diet, fatty acids which are precursors of 
ketone bodies, are metabolized to produce energy. The liver appears to 
be the only organ that adds ketone bodies to the blood. The extrahepatic 
tissues utilize ketone bodies as respiratory substrates. The formation, 
utilization, and excretion of ketone bodies is illustrated in Figure 1. 
Acetone is not readily utilized by the peripheral tissues and, as 
such, is eliminated through the lungs and urine. Acetone is present in 
the blood and is also formed in the lungs by spontaneous decarboxylation 
of acetoacetate as shown in Figure 2 (Trotter, Sulway, and Trotter, 1971; 
Harper, 1973; and Sulway, Trotter, Malins, and Trotter, 1971). 
Breath acetone can be elevated for reasons other than production by 
the liver, as in environmental exposure to acetone. Measurements of 




















Source: Harper (1973}. 
FFA - - - - - --j Acyl CoA 
gluco~ j 
~ · Acet;: C~A 











CH3 - C - COOH 
Acetone 
CH3 - CROH - CH2 - COOH 
8-hydroxybutyric acid 
Figure 2. Spontaneous Decarboxylation of Acetoacetate 
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Ostenson (1966) reported that a man who drank a paint thinner solution 
containing acetone had about 490 gm of acetone in his body. The patient 
did recover without incident. 
Need for Research 
Various gas chromatographic methods to quantitate expired acetone 
have been reported. None were designed, however, to demonstrate reli-
ability, reproducibility, and validity of the method. 
Various methodologies used in this study have not been applied 
previously to measurements of breath acetone. They include: (1) 
utilization of an automatic peak integrator to obtain rapid and objec-
tive acetone concentration values, (2) use of standard acetone gas mix-
tures within the acetone concentration range normally found in human 
breath to construct the standard calibration curve, (3) use of exponen~ 
tial dilution of standard gas mixtures to obtain the standard calibra-
tion curve, (4) determination of the lower limits of acetone 
concentration which can be detected, and (5) utilization of breath sam-
ple collection containers which can be used to transport and store 
samples. 
Quantitation of human breath acetone seems to have certain advan-
tages over quantitation of acetone in urine or blood as follows: 
Expired air is the major route for excretion of acetone (Harper, 1973) 
and concentration of acetone in the breath is believed to be a reliable 
index of the degree of ketonemia (Stewart and Boettner, 1964; 
Krotoszynski, Gabriel and O'Nell, 1977). Elevated breath acetone levels 
can be detected before elevated ketone levels in urine can be detected 
by conventional methods (Stewart and Bottner, 1964). Expired air can 
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be collected without risk and discomfort to the human subject or patient 
(Dubowski, 1974), and monitoring breath acetone at close intervals in an 
individual would be much more desirable than obtaining blood samples at 
close intervals. Thus, its usefulness should be further explored. 
Measurements of breath acetone may have use in improving dietary 
control of diabetes. Through its use, insulin requirements may be 
decreased. For example, it has been generally practiced to treat hyper-
glycemic patients with more insulin. However, breath acetone measure-
ments could lead to improvement of the situation without administering 
more insulin. Crofford, Mallard, Winton, Rogers, Jackson, and Keller, 
(1977) have classified diabetics with hyperglycemia as being in one of 
two categories depending on breath acetone concentration as shown in 
Table I. 
Monitoring blood acetone levels of pregnant women may reduce the 
chances of brain damage to infants which occurs with hyperacetonemia 
(Worthington, Vermeersh, and Williams, 1977). Insulin requirements are 
increased in pregnancy so that ketonemia can readily occur in borderline 
diabetics and even nondiabetics. Breath acetone levels could serve as 
a monitor for this condition. 
Crofford et al. (1977) suggested that breath acetone measurement 
may be useful as a motivational force in following patients on long-term 
weight reduction programs, with the patients instructed to restrict 
caloric intake to such levels that breath acetone is maintained at about 
500 nm. 
In conclusion, an accurate and practical method of measuring breath 
acetone may have a number of useful applications to human nutrition. 
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TABLE I 
CLINICAL USE OF BREATH ACETONE MEASUREllliNT 
Serum Glucose Breath Acetone 
(%} (ruf) Dx Rx 
Greatly elevated Normal (10-50) Overeating Less food 
Greatly elevated High (50} Insulin More insulin 
insufficiency 
Not greatly High (50) Carbohydrate Continue if 







Not greatly Normal (10-50) Good metabolic Continue same 
elevated control Rx 
Purpose of Study 
The general purposes of the study were to develop a gas chromate-
graphic method to determine human breath acetone concentration and to 
demonstrate its use. The specific purposes of the study were to: 
1. Develop an accurate and practical method to quantitate human 
breath acetone levels and demonstrate that it is valid, reliable, and 
reproducible within the range of physiologically realistic concentra-
tions. 
2. Demonstrate the limit of the method to quantitate acetone con-
centration by using an exponential dilution flask. 
6 
3. Demonstrate the validity and reproducibility of the sampling 
procedure and analytical method when using breath samples from relatively 
normal fasting subjects, fasting and non-fasting diabetic patients, and 
£asting obese subjects. 
CHAPTER II 
LITERATURE REVIEW 
Acetone in Humans 
Elevated levels of acetoacetate in blood and urine and the odor-of 
acetone in breath have long been recognized as hallmarks of uncontrolled 
diabetes (Henderson, Karger, and Wrenshall, 1952). The odor of "decay-
ing apples" on the breath of several diabetics was reported as early as 
1798 (Rolo, 1978). Sulway et al. (1971) showed that there were signif-
icant levels of free acetone in the blood of diabetics with hyper-
ketonemia. Ketonuric patients showed increased levels of the three 
ketone bodies before breakfast and insulin administration. Fasting 
breath acetone level was increased in both normal and obese subjects and 
in obese subjects this increase in fasting breath acetone level can be 
used as a guide in caloric reduction (Rooth and Ostenson, 1966). The 
various tablet and dip sticks are not sensitive enough to detect the 
presence of acetoacetate or acetone in the blood, urine, or breath un-
less the patient is under very poor control (Crofford et al. ~· 1977). 
Therapeutic decision can be made more r.ationally if the metabolic state 
of the diabetic is assessed with both blood and breath acetone measure-
ments. 
Crofford et al.. (1977) conclude that a normal range of breath 
acetone concentration in healthy subjects is 10-50 nM. In comparison 
7 
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with the units used in this dissertation. this is approximately 0.58-2.9 
ug/1. Crofford et al. classified patients with breath acetone levels 
less than 50 nM and greatly elevated blood glucose level as hyper-
glycemic. This hyperglycemic condition is induced by overeating and is 
treated by a better dietary management. Crofford et al. also noted that 
treating these hyperglycemic patients with more insulin cannot help to 
improve the condition since more insulin requires overeating and as such 
results in obesity. Hyperglycemia and elevated breath acetone (>50 nM) 
is a sign of inadequate treatment with insulin and, therefore, insulin 
dose should be adjusted. An elevated breath acetone with normal blood 
sugar indicates insufficient carbohydrate intake to meet metabolic need. 
But on the other hand, if the patient is on a weight loss program this 
is a good indicator of success. Those patients.with blood sugar not 
greatly elevated and normal breath acetone (10-50 nM) level are under 
good metabolic control. As such, Crofford et al. further suggest that 
breath acetone measurements are useful motivational forces in following 
patients in long-term weight reduction programs. The patient, in this 
case, restricts his caloric intake to such a level that breath acetone 
concentration is maintained at about 500 nM. If a proper balance of 
dietary carbohydrate, fat, and protein is maintained, then the patient 
can be assured that body fat is being lost at a rate of about one-half 
pound per week. The patient can readily see that dietary indiscretion 
results in immediate normalization of breath acetone concentration. 
Table II summarizes the breath acetone values reported by other 
scientists. It should be noted that the analytical methods between 
researchers differed as well as sampling techniques, such as whole 






























5-319 nM (Range) 
1.3-11.8 ~g/gm condensate/square 
meter of body surface (Range) 
1. 3-12.7 ~g/gm condensate/square 
meter of body surface (Range) 
0.45-9.5 ~g/ml 
1. 6-85.0 ~g/ml (Range) 
0.13-4.22 ~g/L (Range) 
0.13-25.21 ~g/L (Range) 
1.1 ~g/L (Mean) 
30.1 ~g/L (Mean) 
Breath Acetone 
Concentration 
Converted to ~g/L 
0.29-18.50 
Reference 
Crofford et al., 1977 
Henderson et al., 1952 
Levy et al., 1964 
Rooth et al., 1966 
Stewart et a1., 1964 
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sometimes not described as to the presence of diabetic or other disease 
and whether or not they had fasted. Scientists have reported breath 
acetone concentration in different units of measures. These have been 
converted to the units used in this dissertation research, ~g/1, for 
comparison of these results. Where others reported values for blood 
glucose level versus corresponding breath acetone concentration. Because 
standardized methodology has not been used by investigators, it should 
be understood that the figures in Table II serve as only a very general 
guide for comparison with this dissertation research. 
Quantitation, Collection, and Analysis 
of Breath Acetone Concentration 
Breath acetone was first quantified in 1897 by Geelmuyden. Advances 
were made in the method in 1920; Hummard and Widmark measured the con-
centration of acetone in normal humans. The methods were insensitive 
and tedious requiring concentration of the breath sample. Janson and 
Larson (1969) have investigated methods of sampling and analyzing 
organic compounds, including acetone in human breath. Their breath sam-
pling procedure involved the use of collection bags made of polyester 
film (Mylar, DuPont). They used a respiratory mask. The collection 
bags were conditioned twice with breath before actual sample was taken 
from the third filling on the bag so that the composition of the samples 
would not be altered appreciably due to the adsorption of acetone to the 
walls of the bags. Quantitative analysis of the acetone was made by 
using gas chromatograph equipped with a flame ionization detector (FID). 
The flame ionization detector is the best detector for this type of 
analysis since it has a low sensitivity for the inorganic compounds of 
the breath. 
11 
Trotter, Sulway, and Trotter (1971) used gas chromatograph to 
quantitate acetone in breath and plasma. They used aluminum tap assembly 
obtained from "Douglas" bags and patients were asked to rebreath into 
the bags five times and the final exhalation was tapped by closing the 
tap. A 1 ml sample of the breath was directly injected into the column 
of the gas chromatograph. They compared this gas chromatographic tech-
nique with the chemical method and concluded that gas chromatographic 
technique is favorably comparable to an established chemical method. In 
addition, they stated that the gas chromatographic technique is rapid 
and easy to perform. 
Stewart and Boettner (1964) also used gas chromatograph to quanti-
tate and analyze expired air acetone in diabetic patients. They col-
·lected alveolar air sample in saran bags fitted with corkstopper glass 
valves. The collection bags were flushed with continuous stream of air 
for 18 hours to remove volatile contaminants. The acetone concentration 
of the alveolar samples were analyzed by a gas chromatograph equipped 
with a flame ionization detector. Their result showed that juvenile 
diabetics whose urine was negative for ketone bodies had a ten-fold 
greater alveolar air acetone concentration as compared with adult type 
whose urine is negative for ketone bodies. In addition, they shmved 
that there is a cyclic variation of the concentration of acetone for 
those nondiabetic patients during the waking hours. But diabetic pa-
tients with poor control did not show cyclic variation, rather showed a 
steady increase or decrease of acetone concentration. Their findings 
also demonstrated the highest value recorded for conscious patients in 
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diabetic acidosis, 1900 ~g/1. They concluded that in the case of di-
abetic acidosis the expired air acetone concentration appeared to be an 
adequate indicator for clinical response to treatment as any of the 
standard laboratory tests employed. In addition, they indicated that 
the acetone value was a more sensitive and accurate reflection of the 
degree of ketonemia than the reagent-tablet method of semiquantitative 
estimate of plasma or urinary ketone body concentration. They also indi-
cated that a value of acetone concentration less than 3 ~g/L would indi-
cate good metabolic control in the absence of hypoglycemia; a value 
more than 10 ~g/L indicates poor metabolic control, and a value greater 
than 50 ~g/L indicates a state of ketosis. 
Stekelenburg and Bruyn (1970) also used gas chromatograph but their 
technique of sample collection was different, they determined acetone 
concentration by head space analysis. Their technique involved the 
transfer of fresh blood into a vial and let it reach equilibrium. One 
ml of the head space gas was removed and injected directly into the 
column of the gas chromatograph. 
In spite of all the different methods used to analyze breath 
acetone, several investigators have applied breath acetone concentration 
to clinical problems (Roath, 1972; Roath and Tibbling, 1968; Tassopoulos, 
Barnett, and Fraser, 1969; Sulway and Mallins, 1970; Sulway et al., 1971; 
Trotter et al., 1971; Polo and Ilkovo, 1972; Crofford et al., 1977). 
Since no standardized methodology was employed, information on the pre-
cision and reliability of the method of analysis was not given. 
CHAPTER III 
METHODS AND MATERIALS 
A Hewlett-Packard model 5830A gas chromatograph equipped w·ith a 
flame ionization detector, an automatic 0.5 ml gas sampling valve and 
utilizing an exponential dilution flask (Figure 3) was used. It has 
6 foot stainless steel matched dual columns, 1/8 inch SS packed with 
0.1% Sp-1000 on carbopack C, recommended because of tis inertness gives 
good symmetry with polar compounds. Other operating parameters were: 
oven temperatures of 120°C, 130°C, 140°C, and 150°C; FID temperature of 
350°C; chart speed of 0.8 em/min.; peak attenuation of 210 , 28 , 24 , 22 ; 
slope sensitivity of 1 for concentrations above 5 ~g/L and 0.5 for con-
centrations below 2.5 ~g/L; area rejection of 1; carrier (He) gas flow 
through the dual columns 34 to 35 ml/min; nitrogen flow rate through the 
exponential dilution flask of 19.9, 26.2, 30.8~ 37.7, 41.7, 42.9, 43.5, 
and 46.8 ml/min.; hydrogen and air entered the burner at a flow rate of 
35 and 250 ml/min., respectively. 
The exponential dilution flask (EDF) is a device used for calibra-
tion of detectors with gas samples. It consists of a glass vessel with 
a diluent gas inlet and an outlet. The outlet is connected to a gas 
sampling valve (GSV) for introduction of the sample into a gas chromato-
graph. A gas-tight syringe was used to introduce a known volume of the 





A & B == sampling valves, C & D = carrier gas, E = injec-
tion port, F = flow regulator, G = Nz cylinder, H = to 
pump, I = needle valve, J = pressurizer, 1 = valve 1, 
2 valve 2, 3 = valve 3, 4 = valve 4, 5 c valve 5, 
6 & 7 = 0.5 ml sample loop. 




The volume of the exponential dilution flask was determined by 
weighing the flask before and after being filled with water (volume of 
flask in this study was 165.85 ml). The flow rate of nitrogen through 
the exponential dilution flask was measured by the use of a soap film 
flowmeter. 
The gases are mixed in the exponential dilution flask by a stirring 
vane, and an exponential dilution of the sample gas in the diluent is 
achieved with time (Hammarstrand, 1976). 
The concentration of the exponentially diluted acetone (commercial 
standard gas mixtures and head space above laboratory prepared acetone 
in ethyl acetate standards) injected into the exponential dilution flask 
was determined by the following formula (Shatting, 1969; Scolnick, 1970; 
Ritter and Adams, 1976; Mitchell, 1972): 
where: 
VA volume of acetone injected in ~1 
DA =density of acetone (0.790 mg/ml) 
MA = molecular weight of acetone (58.00 mg/ml) 
VE = volume of exponential dilution f_lask (165.85 ml) 
DN = density of nitrogen (1.252 mg/ml) 
~ molecular weight of nitrogen (28.00 gm/mole). 
The gas chromatograph was programmed for each run. Time for each 
peak was calculated by using the formula given below, and this formula 
was used to detern1ine the concentration of the sample (C.) at any time 
J.. 







VE ~ volume of exponential dilution flask 
Q nitrogen flow rate through the exponential dilution flask in 
ml/minute 
ln natural logarithm 
C initial concentration of acetone at T 
0 0 
Ci concentration of acetone at timeT. 
Three 1,000 ml volumetric flasks were silylated in order to avoid 
adsorption of acetone on the vmlls of the flasks (Grab, Grab, and Grab, 
1977; Sandra and Verzele, 1977). The volumetric flasks were filled with 
20% HCl (hydrochloric acid) solution and stored for three days. The 
flasks were washed with distilled water, and 3 ml of 1,1,1,3,3,3-Hexa-
methyldisilazane was poured into each volumetric flask. The flasks were 
fitted with stopcocks and evacuated for 3.3 minutes by using a pump. 
After evacuation the volumetric flasks were placed in an oven at a 
temperature of 300°C so that the hexamethyldisilazane could react. The 
silylated flasks were used to prepare and calculate the concentration of 
acetone in ethyl acetate standard~ (Hala, Wichterle, Potak, and Boublik, 
1968): 
where: 
log P 0 
1 
Pl pure vapor pressure of acetone 
t room temperature in degrees Celsius 
A1 are Antoine's constants for vapor pressure equation given with 
Bl 
c1 respective temperature regions in degree Celsius. 
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where: 
a12 = relative volatility 
x1 = mole fraction of acetone in the liquid phase 
x2 mole fraction of ethyl acetate in the liquid phase 
y1 = mole fraction of acetone in the vapor phase 
y2 = mole fraction of ethyl acetate in the vapor phase. 
When assuming ideal behavior of vapor phase, a12 can be defined as: 
0 
ylPl 
. al2 = Yl2 
where: 




pure vapor pressure of ethyl acetate 
yl activity coefficient of acetone 
Yz activity coefficient of ethyl acetate. 
The equilibrium composition of liquid and vapor phase in a two 
component system of nonelectrolytes is expressed as: 
where: 
a12 = relative volatility 
x1 = mole fraction of acetone in the liquid phase 
x2 = mole fraction of ethyl acetate in the liquid phase 
y1 mole fraction of acetone in the vapor phase. 
where: 
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PA = partial pressure of acetone in the flask 
yl mole fraction of acetone in the vapor phase 
yl = activity coefficient of acetone 
pO 
1 





Nl number of moles of acetone 
PA partial pressure of acetone in the EDF 
Vsyr = injection volume in liters 
R gas constant 
K z:: degree Kelvin 
Techniques Used for Calibration and 
Standardization 
1. Head space above laboratory prepared acetone in ethyl acetate 
standards injected by syringe: The concentration of acetone in ethyl 
acetate standard was calculated by using room temperature, the vapor 
pressure of acetone, mole fraction of acetone in the liquid phase, activ-
ity coefficient of acetone, partial pressure of acetone in the flask, the 
ideal gas law, and the flame ionization detector (FID) response factor 
for acetone and ethyl acetate (see equations given on pages 16-18). Some 
of the prepared acetone in ethyl acetate standard was transferred into a 
125 ml evacuated bulb and was allowed to reach equilibrium with its 
liquid phase. A gas-tight syringe was inserted through the septum that 
closes the opening of the bulb containing the standard and a 10 ].11 of the 
vapor was drawn. The plunger of the syringe was repeatedly moved to and 
fro (10 times) and held in the bulb for one minute before the 10 ~1 
sample was drawn. This sample was directly injected into the gas 
chromatograph through the stainless steel gas valve fitted with an 
adapter which provides a tight fit between the injection port and the 
syringe which contained the sample. A Supelco, Inc., Thermogreen LB-1 
septum (0.5 mm) was placed in the fitting valve of the injection port. 
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As the sample passed through the column, the different components were 
differentially retarded by adsorption or absorption by the column fill-
ing material. As the carrier gas (He) continually flowed through the 
column, acetone and ethyl acetate were eluted at different times. The 
effluent from the column entered the burner base through a millipore 
filter and was mixed with the hydrogen entering the burner and burned in 
filtered air. During this combustion, ionic fragments and free electrons 
are formed. These ions and free electrons produce an electric current 
proportional to the rate at which the sample enters the flame. Under the 
conditions stated above, acetone emerged from the column and was detected 
56 seconds after injection of the sample (Figure 4). 
2. Head space above laboratory prepared acetone in ethyl acetate 
standards injected by automatic sample loop after exponential dilution: 
Valves 3 and 4 (Figure 3) were opened to allow the nitrogen to flow 
through the exponential dilution flask so that any contamination was 
swept out through vent 1 or 2. Valves 3 and 4 were closed, and 195 ~1 
of the vapor of acetone in ethyl acetate standard was injected into the 
exponential dilution flask through the injection port of the EDF and 
mixed for 1 1/2 minutes. Thorough mixing is required for better results 
(Ritter and Adams, 1976). Valves 3 and 4 were opened (to allow a con-
tinuous flow of nitrogen to dilute the sample) at the same time and the 
~. 4 '5 
~Acetone l . ~ 1 
'-::::======-=-~~· . 2 1 
~Ethyl Acetate 
FID Response (Arbitrary Units) 
Figure 4. Typical Chromatogram of Acetone Peak, Actual Size 
N 
0 
actuator button was pressed. The gas chromatograph was programmed to 
sample at a given time and time for each concentration was calculated 
by the formula given on page 16. 
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3. Commercially obtained acetone standard injected by an automatic 
sampling loop from sampling bags: The sample bags were filled with com-
mercial standard (acetone) gas mixtures and the acetone was pulled from 
the bags into the sample loop by the use of a pump (Figure 3). 
4. Commercial standard (acetone) gas mixtures injected by an auto-
matic sample loop after exponential dilution: The exponential dilution 
flask was filled with commercial acetone standard and was diluted by a 
continuous flow of nitrogen through the exponential dilution flask. The 
gas chromatograph was programmed to sample at given times and time for 
each concentration was calculated by the use of the formula given on page 
16. 
Duplicate samples were collected for each column temperature, flow 
rate, day, and run chosen. The day-to-day variations and the run-to-run 
variations were studied. All other conditions were held constant while 
temperature and flow rates were varied to determine which flow rate 
temperature combination fitted the standard curve best. Statistical 
analyses on the different procedures were made to measure the effects of 
flow rate changes, day-to-day variation, run-to-run variation within a 
day and bet\veen duplicate variations. 
Collection of Expired Air 
Breath acetone samples from normal, obese and diabetic patients were 
collected by a 12 by 12 inch Mylar bag (especially constructed sampling 
bags, Payne-Bose, Tsegaye, Morrison, and Waller, 1978). Two drying 
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columns, one packed with Drierite (anhydrous Caso4 , to absorb water), 
and the other with barium hydroxide lime (to absorb co2) were connected 
to the Mylar bag by a tygon tubing. A 3-cm tygon tubing was slipped into 
the top column to serve as a mouthpiece. Subjects were asked to breath 
through the mouthpiece thereby inflating the bag. The concents of the 
bags were introduced into the column of the gas chromatograph through the 
0.5 ml automatic sample loop. Duplicate samples were drawn from each bag 
to demonstrate reproducibility. Samples were stored in the bags for more 
than three days and analyzed to check if there was variation because of 
storage or adhesion to the walls of the bags. 
Subjects 
Breath acetone concentration of 56 diabetic and healthy subjects 
were determined. Postparandial and fasting breath samples of 42 diabetic 
out-patients of the Veteran Administration Hospital in Oklahoma City, 
three well controlled and one brittle diabetic subjects from Stillwater 
were collected and analyzed. Fasting breath samples of one obese and 
nine normal (lean) subjects were also collected and analyzed. Twenty-
seven of the 46 diabetic subjects were insulin dependent. The concentra-
tion of acetone in the sample breath was compared with the blood sugar 
level. Proper statistical procedures were used to analyze the data. 
CHAPTER IV 
RESULTS A..~D DISCUSSION 
There were no differences in the peak areas due to the different 
column temperatures used. The difference on area count due to flmv rate 
(nitrogen flow through the exponential dilution flask) was not signif-
icant at a= 0.05 (Table III). 
There was a significant difference in area count due to test dates 
at a= 0.005 (Table IV and Figure 5). When the curves obtained by using 
two different procedures (the exponential dilution flask procedure and 
sampling from bags procedure) for each of the two sources of acetone 
were compared, it was found that the four fitted straight lines were 
parallel (Table V). However, it was also found that there was a differ-
ence due to the source of acetone and differences due to procedures. A 
higher degree of polynomial effect was found for each curve and the shape 
of the curves were not the same. All of these differences were signif-
icant at a < 0.05. 
When three concentrations of commercial acetone standards were 
analyzed by the two different procedures, it was found that there was a 
difference between procedures (a< 0.05). The two fitted straight lines 
were parallel, but there was a quadratic effect. The curvatures were not 
the same for both procedures. 
When direct injection procedure was compared with the exponential 
dilution flask (EDF) procedure, it was found that there was a significant 
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TABLE III 
ANALYSIS OF VARIANCE OF ACETONE PEAK AREA FOR THE 
DIFFERENT FLOW RATES 
24 
Source df Mean Square Values for F 
Flow Rate (Q) 
Time Linear (T2) 
Time Linear in Flow Rate T1 (Q) 
Time Quadratic (T2) 
Time Quadratic in Flow Rate T2 (Q) 
Time Residual in Flow Rate 
Run in Flow Rate (= error a) 
T _ i> Run in Flow Rate 
j_ 
T2 *Run in Flow Rate 
Residual Time ·k Run in Flow Rate 
(= error b) 






















ANALYSIS OF VARIANCE OF ACETONE LOGARITHM PEAK AREA FOR THE 
DIFFERENT TEST DATES 
Source df Mean Square Values for 
Test Dates 2 0.321910245 76.945* 
Run in Test Dates (= error a) 3 0.00418366 
Time Linear (Tl) 1 33.01588093 789.069* 
Time Quadratic (T2) 1 0.20246885 48.395'1'~ 
Time Residual 11 0.000615155 0.147 
Time Linear .,.~Test Dates 2 0.034695675 8.293* 
Time Quadratic .,.~Test Dates 2 0.00650963 1.556 
Time Residual *Test Dates 22 0. 00007793 0.186 
Time Linear * Run in Test Dates 3 0.00152476 0.346 
Time Quadratic,·~ Run in Test Dates 3 0.00006795 0.016 
Time Residual * Run in Test Dates 
(= error b) 33 0.00000837 
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TABLE V 
ANALYSIS OF VARIANCE OF ACETONE LOGARITHM PEAK AREA OF THE 
FOUR PROCEDURES AND THE TWO SOURCES 
27 
Source df Mean Square Values for F 
Total 120 
Procedures and Sources (P-S) 3 
Test Dates in (P-S*Log Concentration) 
(= error a) 18 
Log Concentration Linear (common slope) 1 
Log Concentration Linear in (P-S) 
parallelism 3 
Log Concentration Residual in (P-S) 
curvature 
Runs in (P-S and Test Dates) = error b 
1 Run in Test Dates for Com-EDF 
2 Run in Test Dates for Lab-EDF m 
Run in Test Dates for Direct 
Sampling from Bag 
Run in Test Dates for Direct 
Injection 







4. 34405173 114890.0* 
0.00378103 99958.0* 








1cornmercial standard acetone mixture sampled through exponential dilution 
flask. 
2 Laboratory prepared acetone standard sampled through the exponential 
dilution flask. 
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difference between the responses (a< 0.005). However, the slope of the 
two straight lines relationship between log area and concentration were 
parallel. There was a quadratic effect in the injection technique. 
The quadratic effect in the exponential dilution flask could not be ob-
tained since only two concentrations of acetone were used. 
When the laboratory prepared acetone standard curve obtained by 
using the exponential dilution flask procedure was compared with the 
commercial standard curve obtained by the same procedure, it was found 
that there was a significant difference (a < 0.005) due to the type of 
acetone standard used. The two linear responses were parallel. It was 
also found that there was a quadratic effect in the commercial standard 
curve obtained by utilizing the exponential dilution flask. 
When the two different procedures for each of the two different 
acetone sources were tested for precision (Table VI), it was found that 
direct sampling of commercial standard acetone from the bags through the 
sampling loop had a smaller variance and was more precise than the 
procedure which utilized the exponential dilution flask (EMS c 0.00000395 
and 0.00199545 respectively). The error mean square for the laboratory 
acetone standard curve utilizing the exponential dilution flask was found 
to be of the same magnitude (0.001968796 vs. 0.00199545) as that of the 
commercial standard curve utilizing the exponential dilution flask. 
The technique (procedure) of direct injection by the use of a 
syringe using laboratory prepared acetone standard was compared with that 
which utilized the exponential dilution flask (Table VI). It was found 
that direct injection technique had a better precision than the exponen-
tial dilution flask technique (EMS = 0.0009058 vs. 0.00196879 respec-
tively). Statistical analysis showed that the two procedures gave 
TABLE VI 
COMPARISON OF LOGARITHM OF PEAK AREAS BETWEEN EXPONENTIAL DILUTION 
FLASK AND DIRECT INJECTION PROCEDURES USING 
LABORATORY PREPARED ACETONE 
29 
Source df Mean Square Values for F 
Total 86 
Procedure 1 3.92287333 1038.00* 
Test Dates in Procedure and Concentra-
tion (= error a) 7 0.00868842 
Log Concentration Linear .1 25.69790495 6795.00* 
Log Concentration Linear in Procedure 
(parallelism) 1 0.00191634 0.51 
Log Concentration Quadratic in 
Procedure 1 0.28501309 75.40* 
Log Concentration Residual in 
Procedure 2 0.01302183 13.51* 
Runs in Procedures and Concentration 
and Test Dates (= error b) 73 0.00096405 
*Significant at 0.005 probability level. 
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significantly different responses (a< 0.005). Even though the two 
linear lines were parallel there was a quadratic effect present. 
Analysis of the data from application of the procedure on human 
subjects is shown in Table VII and Figure 6. The concentration of 
acetone in the unknown breath samples was calculated by using the equa-
tion for the standard curve (Figure 7). The value obtained by using this 
curve gave essentially the same results as that obtained by direct sam-
pling from the bags. 
Discussion 
The exponential dilution flask was designed to be an accurate proce-
dure to calibrate the detector of the gas chromatograph. A sketch of two 
runs on the same day of log area peak with respect to times is shown in 
Figure 8 (Appendix F). Although the two lines essentially coincide, it 
was found that runs on different days do not give this precision. This 
study showed that direct sampling from sampling bags through the auto-
matic gas sampling loop has a better precision. 
Since there is a significant variation between test dates, it is 
recommended to calibrate the gas chromatograph every day when unknown 
samples are run. 
This study demonstrates that gas chromatograph equipped with a flame 
. 
ionization detector is sensitive, rapid, and reliable to measure breath 
acetone concentration. The concentration of acetone in the sample is 
given as a peak area (Figure 6) by the instrument. 
Nineteen of the 46 diabetic patients studied had breath acetone con-
centrations ranging from 3.58 ~g/L to 13.50 ~g/L. Normal subjects have 
fasting breath acetone concentrations ranging from 0.66 0g/L to 1.10 ~g/L 
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TABLE VII 
BREATH ACETONE CONTENT OF DIABETIC PATIENTS 
Patients on Insulin Thera12y Patients Without Insulin Therapy 
Serum Serum 
Glucose Breath Acetone Glucose Breath Acetone 
Initial (mg%) in ]lg/L Initial (mg%) in JJg/L 
E.S. 230 4.40 B.G. 220 0.59 (Fasting) 
C.H. 290 2.85 J.A. 170 1.16 (Fasting) 
T.L. 220 0.54 T.G. 300 0.22 (Fasting) 
M.B. 400 5.40 p.M. 300 3.75 (Fasting) 
L.H. 220 5.30 J.E. 100 3.75 (Fasting) 
M.D. 230 6.13 J.Y. 320 4.26 
J.B. 120 1.88 T.H. 220 1. 32 
J .R. 240 4.95 R.P. · 130 2.32 
J.G. 240 9.06 E.H. 240 8.17 
O.B. 400 0.96 G.P. 220 2.44 
B.K. 270 12.73 E.G. 190 1. 28 
K.F. 210 4. 64 c .w. 120 7. 57 
v.c. 120 0.97 R.H. 360 0.93 
w.w. 260 2.55 L.W. 200 1.01 
R.J. 240 5.75 G.J. 300 3.99 
E.D. 260 13.48 H.W. 260 1. 86 
M.W. 220 2.00 B.B. 220 1.89 
· G.S. 300 0.53 
R.L. 180 1.77 
M.L. 240 3.48 (Fasting) 
H.L. 150 3.14 (Fasting) 
J.M. 380 2.36 
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(Stewart and Boettner, 1964; Rooth and Ostenson, 1966); thus, these 
diabetic subjects had elevated breath acetone concentrations. Their 
serum glucose levels ranged from 100 mg% to 400 mg% (Table VII). These 
people were under poor metabolic control (Stewart and Boettner, 1964; 
Crofford et al., 1977). Patients who did not fast but were on insulin 
therapy showed higher concentrations of breath acetone, 13.48 ~g/L (Table 
VII) as compared to 10.18 ~g/L for those patients who fasted and were on 
insulin therapy. Patients who did not fast and were not on insulin 
therapy had higher breath'concentration (8.17 ~g/L) than those patients 
who fasted and were not on insulin therapy (3.75 ~g/L). Using Crofford 
et al. 's (1977) classification of diabetic control, considering both 
serum glucose level and breath acetone concentration: 16 were overeat-
ing, 17 administered insufficient insulin, 2 consumed insufficient 
dietary carbohydrates, and 2 were under good metabolic control (Table 
VIII). 
Determination of breath acetone concentrations in addition to deter-
mination of blood glucose level allows more accurate control of the 
diabetic state by better dietary management than determination of blood 
glucose level alone. In this way, control may be achieved by dietary 
changes rather than increases in insulin administration. 
The procedures developed in this study may also have possible 
application in veterinary medicine to monitor breath acetone levels in 
animals such as dairy cattle, as well as other areas of forensic science 
to determine the alcohol concentration in the blood. 
TABLE VIII 
INTERPRETATION OF RESULTS OF BREATH ACETONE CONCENTRATION 
AND BLOOD GLUCOSE M~ALYSES 
Serum Glucose Breath Acetone 
(mg%) (Jlg/L) Dx Rx 
Greatly elevated Normal Overeating Less food 
(130-400) (0.22-2.85) 
Greatly elevated High Insulin More insulin 
(150-400) (3 .14-13. 48) insufficiency 
Not greatly High Carbohydrate Continue if 








Not greatly Normal Good Continue same 




A gas chromatographic method to determine human breath acetone con-
centration has been developed. It has been shown that as little as 0.22 
pg/L of breath acetone can be detected. 
Method development included four different techniques for obtaining 
the standard curve. Two different types of standard mixtures were used: 
commercial s·tandard gas mixtures of acetone in nitrogen and head space 
above prepared acetone in ethyl acetate standards. The commercial stand-
ard gas mixtures were introduced into the gas chromatographic column by 
an automatic sampling loop both directly from especially constructed sam-
pling bags and after exponential dilution. The head space above labora-
tory prepared standards were introduced into the column by syringe 
through an injection port and after exponential dilution through the 
automatic sample loop. 
Statistical analysis showed that sampling directly from laboratory-
constructed sample bags through the automatic sampling loop to be the 
more precise procedure than using the exponential dilution flask (EMS 
0.00000395 vs. 0.00199545 respectively). The head space above labora-
torY' prepared and CO!lL'Uercially obtained acetone standards utilizing the 
exponential dilution flask had the same error mean square (0.001968796 
vs. 0.0019545). In addition, it was shown that direct injection by the 
36 
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use of a syringe is a more precise technique than the exponential dilu-
tion flask (EMS= 0.0009058 vs. 0.001968796 respectively). 
It has been shown that the four sets (Table V) appear to be quite 
similar in predicting area in respect to concentration. However, in 
spite of the parallelism of the lines, they do not coincide. Statistical 
analysis has shown that direct sampling from bags through the sampling 
loop is by far the better procedure than the one using the exponential 
dilution flask. Whatever procedure is chosen, it is important that the 
researcher is consistent. 
In conclusion, the method developed was demonstrated on subjects 
with breath acetone concentrations ranging from 0.22 ~g/L in a healthy 
nondiabetic to 13.5 ~g/L in a poorly controlled diabetic representing 
about a 60-fold difference in concentration. 
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CALCULATIONS OF DIFFERENT CONCENTRATIONS OF 




INDIVIDUAL CALCULATIONS OF THE DIFFERENT CONCENTRATIONS 
OF ACETONE IN ETHYL ACETATE STANDARD 
Acetone in Ethyl Acetate 1:500 
A = 1 7.117 A2 7.102 
B = 1 1210.595 B2 1244.950 
c = 1 229.664 c = 2 217.881 
R = 0.082 x1/x2 = 2 x 10-3 
injection volume = 1 x lo-5 L 
0 1210.595 
log pl = 7 · 117 - 24.5 + 299.664 
P0 = 255.99 
1 
(1.18) (255.99) 
a12 = (1.13)(92.35) 
(2.555)(2 X 10-3) 
y = 
l 1 + 2.555 (2 X 10-J) 
0.00508 
pl = 0.00508 X 1.18 X 225.99 
0.533 
(0.533)(1 X 10-s L) 
N1 = 760 X 0.082 X 297.5 
= 2.873 x 10-lO moles 
2.873 X 10-l nM 
Room 
= 













TABLE IX (Continued) 
Acetone in Ethyl Acetate 1:100 
0 1210.595 
log pl = 7•117 - 24.5 + 229.664 
0.01 
0.99 
x1/x2 = 0.01 
injection volume = 1 x 10-5 L 
225.992 
= -:-(_1._1_8~) -:--(2_2_5_. 9--:-9~) 
(1.13) (92.35) 
c 2. 555 
(2. 555) (0. 01) y = -:---'---:-:---::-':-:--:'7--:-::----':--:-
1 1 + (2.555)(0.01) 
= 0.025 
pl = 1.18 X 0.01 X 225.99 
= 2. 667 
(2.667)(1 X 10-5 L) 
Nl = l60 X 0.082 X 297.5 
= 1.438 x 10-9 moles 
1.438 nM 




log P1 24.5 + 229.664 Room 
pl 225.992 
temperature= 24.5° 
X = 1 0.02 
X = 2 0.98 
yl = 1.18 
Y2 1.13 
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TABLE IX (Continued) 
Acetone in Ethyl Acetate 1:50 (Continued) 
(2. 5554) (0.020408) 
y = 1 1 + (2.554)(0.020408) 
0.05 
pl = (0.02)(1.18)(225.99) 
5.33 
(5.33)(1 x 10~5 L) 
Nl = 769 X 0.08205 X 297.5 
= 2.87 x 10 moles 
:c: 2.87 nM 
Acetone in Ethyl Ac~tate 1:10,000 
0 1210.595 
log Pl = 7.11714- 22 + 229.664 
P0 = 202.66 
1 
(2.592)(1 X 10-4) y = _ _,___:._:_.~~----'---'----.,...-
1 1 + (2.592 X 1 X 10-4) 
0.0259 
pl = 1.18 (0.0001)(202.6645) 
= 0.02391 
0.0239 (1 X 10-5 1) 
N == -=:-:-----'"--::---------'-
1 760 X 0.08205 X 295 
-11 = 1.3 x 10 moles 
-2 1.3 X 10 nM 
Room temperature = 22°C 
X = 0.0001 
1 
x 2 = 0.9999 
-4 x1/x2 = 1 x 10 
Injection volume = 1 x 10-S L 
yl = 1.18 
y 2 = 1.13 
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TABLE IX (Continued) 
Acetone in Ethyl Acetate 1:5000 
0 . 1210.595 
log pl = 7•11714 - 21.5 + 229.664 
P0 = 198.24 
1 
y = -~< 2:...:·.::...5:__;9 9:..!.)~(-=.0.:.,... 0::._:0:..::0=-2 !-:/ 0:..:•,-::.0.:_00::..:2~)--:-
1 1 + 2.59968(0.0002/0.00022. 
= 0.0005 
pl = 1.18 X 0.0002 X 198.244 
= 0.046 
0.4678 (1 X 10-5 L) 
Nl = 760 X 0.08205 X 294.5 
= 2.54788 x 10-ll moles 
2.55 X 10-2 nM 
Room temperature= 21.5°C 
X = 0.0002 
1 
X = 0.9999 2 
X/x2 = 0.0002 
y1 = 1.18 
y2 = 1.13 
Acetone in Ethyl Acetate 1:1000 
0 7 11714 1210.595 
log pl = • - 21.5 + 229.664 
P0 = 198.2444 
1 
(2.59968)(0.001/0.999) 
y = 1 1 + 2.59968(0.001/0.999) 
= 0.00259 
0.233 (1 X 10-5 L) 
N = 1 760 X 0.8205 X 294.5 
= 1.2738 x 10-lO moles 
= 1.2738 X 10-1 nM 
Room temperature = 21.5°C 
X = 0.001 
1 
X = 0.999 
2 
x1/x2 = 1 x 10-3 
Injection volume = 1 x 10-5 L 
yl = 1.18 
y2 = 1.13 
APPENDIX B 
DILUTION OF THE DIFFERENT SOURCES OF STANDARD 































Time Concentration (Arbitrary 
in min. (Jlg/1) Units) 
Initial Concentration = 97 Jlg/1 
0.65 50.0 4965 
2.65 30.0 3656 
4.35 20.0 2569 
7.25 10.0 1430 
10.15 5.0 806 
13.06 -2.5 469 
16.86 1.0 238 
19.77 0.5 150 
Initial Concentration = 5.18 Jlg/1 
0.65 5.0 726 
2.65 3.0 435 
4.35 2.0 280 
7.25 1.5 211 
10.15 1.0 138 
13.06 0.5 58 
Initial Concentration = 56.98 Jlg/1 
1.17 50.0 4533 
2.17 40.0 3621 
5.27 20.0 1801 
8.37 10.0 921 
11.58 5.0 470 
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TABLE X (Continued) 
Flow Rate Retention Expected Area 
in Time Concentration (Arbitrary 
m1/min. in min. (~g/1) Units) 
36.8 14.68 2.5 253 
36.8 16.99 1.5 161 
36.8 18.79 1.0 124 
36.8 21.89 0.5 77 
Initial Concentration = 195 Jlg/1 
36.9 o. 65 100.0 8284 
36.9 2.85 60.0 5555 
36.9 4.65 40.0 3794 
36.9 7. 7 5 20.0 2162 
36.9 10.85 10.0 1565 
36.9 14.25 5.0 846 
36.9 17.15 2.5 491 
36.9 19.45 1.5 378 
36.9 21.25 1.0 300 
36.9 24.35 0.5 202 
Initial Concentration = 274.54 llg/1 
40.1 0.97 250.0 30490 
40.1 1.87 200.0 25210 
40.1 3.07 150.0 19790 
40.1 4. 77 100.0 13850 
40.1 7.67 50.0 7454 
40.1 8.57 40.0 6152 
40.1 9. 77 30.0 4874 
so 
TABLE X (Continued) 
Flow Rate Retention Expected Area 
in Time Concentration (Arbitrary 
ml/min. in min. (Jlg/1) Units) 
40.1 11.37 20.0 3559 
40.1 14.28 10.0 2064 
40.1 17.18 5.0 1249 
40.1 20.08 2.5 778 
40.1 22.18 1.5 575 
40.1 23.88 1.0 465 
40.1 26.69 0.5 342 
APPENDIX C 
DIRECT SAMPLING OF THE DIFFERENT ACETONE 
STANDARDS AND DETECTOR RESPONSE 
EXPRESSED AS PEAK AREA 
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TABLE XI 
DIRECT SAMPLING OF C0}~1ERCIALLY PREPARED ACETONE 
AND REPORTED AREA (ARBITRARY UNITS) 
Concentration 
in )lg/1 Run Area 
56.98 1 4638 
56.98 2 4667 
56.98 1 4283 
56.98 2 4262 
56.98 1 4413 
56.98 2 4461 
56.98 1 4578 
56.98 2 4528 
5.18 1 954 
5.18 2 959 
5.18 1 954 
5.18 2 957 
5.18 1 963 
5.18 2 963 
5.18 1 960 
5.18 2 962 
274.54 1 36820 
274.54 2 36530 
274.54 1 36430 
274.54 2 36300 
274.54 1 36150 


























DIRECT INJECTION OF LABORATORY PREPARED ACETONE 
AND REPORTED AREA (ARBITRARY UNITS) 
Concentration Room Temperature Peak Height 
in ].lg/1 in °C Attenuation in em 
147.9 21.5 2 5.8 
147.9 21.5 2 6.0 
147.9 21.5 3 3.5 
147.9 21.-5 3 3.7 
147.9 21.5 3 3.4 
147.9 21.5 3 3.7 
147.9 21.5 3 3.6 
147.9 21.5 3 4.0 
147.9 21.5 3 4.1 
147.9 21.5 3 4.1 
147.9 21.5 3 4.1 
147.9 21.5 3 3.8 
1.392 X 10 5 21.0 4 15.7 
1.392 X 105 21.0 5 15.8 
1. 392 X 105 21.0 5 15.8 
1.392 X 105 21.0 5 15.8 
1.392 X 105 21.0 5 15.8 
1. 392 X 105 21.0 5 15.7 
1.392 X 105 21.0 5 15.7 
1.392 X 105 21.0 5 15.7 
75.1 20.5 3 1.4 


























TABLE XII (Continued) 
Concentration Room Temperature Peak Height 
in ]..lg/1 in °C Attenuation in em Area 
75.1 20.5 3 1.5 156 
75.1 20.5 3 1.3 138 
75.1 20.5 3 1.5 158 
75.1 20.5 3 1.5 157 
75.1 20.5 3 1.3 137 
75.1 20.5 3 1.4 147 
75.1 20.5 3 1.5 159 
1. 666 X 10 3 21.0 5 7.2 3171 
1. 666 X 10 3 21.0 4 15.2 3290 
1. 666 X 103 21.0 4 15.1 3322 
1. 666 X 103 21.0 4 15.7 3460 
1. 666 X 103 21.0 4 15.1 3324 
1.666 X 103 21.0 4 15.7 3450 
1.666 X 103 21.0 4 15.7 3434 
1.666 X 10 3 21.0 4 15.4 3383 
1.666 X 10 3 21.0 4 15.7 3432 
1. 666 X 10 3 21.0 4 15.6 3430 
7.38 X 102 21.0 4 "7.5 1377 
7.38 X 102 21.0 4 7.9 1483 
7.38 X 102 21.0 4 7.5 1404 
7.38 X 102 21.0 4 7.7 1417 
7.38 X 102 21.0 4 8.9 1640 
7.38 X 102 21.0 4 8.8 1631 
7.38 X 102 21.0 4 9.0 1644 
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TABLE XII (Continued) 
Concentration Room Temperature Peak Height 
in )lg/1 in °C Attenuation in em Area 
7.38 X 102 21.0 4 8.1 1502 
7.38 X 102 21.0 4 7.8 1461 
7.38 X 102 21.0 4 8.4 1541 
7.38 X 102 21.0 4 8.7 1585 
APPENDIX D 
DETECTOR RESPONSE TO BREATH ACETONE 





BREATH ACETONE RESPONSE OF DIABETIC SUBJECTS 
Patient Bag No. Duplicates Area 
E.D. 4 1 1068 
E.D. 4 2 1036 
B.K. 88 1 900 
B.K. 88 2 915 
J.E. 9 1 1019 
J.E. 9 2 1026 
R.J. 3 1 354 
R.J. 3 2 401 
F.B. 229 1 951 
F.B. 229 2 892 
R.J. 9 1 480 
R.J. 9 2 479 
J.E. 2 1 548 
J.E. 2 2 552 
E.S. 6 1 379 
E.S. 6 2 381 
C.H. 720 1 247 
C.H. 720 2 244 
T.H. 112 1 127 
T.H. 112 2 164 
B.B. 89 1 167. 
B. B. 89 2 164 
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TABLE XIII (Continued) 
Patient Bag No. Duplicate Area 
R.P. 201 1 12 
R.P. 200 2 12 
M.B. 468 1 502 
M.B. 469 2 502 
E. H. 708 1 102 
E.H. 708. 2 102 
D.S. 777 1 239 
D. S. 777 2 239 
L.H. 459 1 503 
L.H. 461 2 503 
G.P. 211 1 237 
G.P. 210 2 237 
M.B.A. 531 1 19 
M.B.A. 537 2 19 
E.C. 111 1 83 
E.C. 109 2 83 
c.w. 656 1 248 
c. w. 660 2 248 
J.B. 163 1 250 
J.B. 162 2 250 
APPENDIX E . 





BREATH ACETONE CONCENTRATION OF NORMAL FASTING SUBJECTS 
Breath Acetone (].lg/1) Initial 
1. 56 D.G. 
1.37 A.D. 
4.66 B.S. 
0. 77 J.M. 
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Note: 1 and 2 are duplicate samples. If the.areas at a given time are equal, only one value is 
printed for that area. There are three hidden observed values in the above figure. 
Figure 8. Logarithm of Peak Area of Acetone Versus Time of Sampling from the 
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0.2 o.4 o." o.d 1.0 1.2 t.4 1.6 1.e 2.0 z,z z., 2.6 z.a 
Log of Concehtration 
Note: If areas for duplicates at a given time are equal, only one value is printed. -Th:ere are 93 
observed values hidden. C = commercial acetone standard using the.exponential dilution 
flask, D = direct injection of head space acetone iu ethyl acetate standard, L = head space 
acetone in ethyl acetate standard using the exponential dilution flask, S == commercial 
acetone standard sampled directly from collection bags. The values in parentheses indicate 
the number of observations for the corresponding concentration. 
Figure 9. Logarithm of Reported Peak Area Versus Logarithm of Acetone Concentration 
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Log of Concentration 
Note: If areas for·duplicate samples at a given time are equal, only one value is printed. There 
are six additional observed values hidden. C = commercial acetone standard, L = head space 
acetone ~n ethyl acetate standard. The values in parentheses indicate the number of 
observations for the corresponding log concentration. 
Figure 10. Logarithm of Reported Area of Acetone Peak Versus Logarithm of Acetone Concentra-
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Note: · D = direct injection, L = sampling from the exponential dil~tion flask. If areas for 
duplicate samples are equal at a given time, only one value is printed. There are 66 
additional observed values hidden. The values in parentheses indicate the number of 
observations for the corresponding log concentration. 
Figure 11. Logarithm of Reported Area of Acetone Peak Versus Logarithm of Acetone Con-
centration--Comparison Between the Two Procedures (Direct Injection Versus 
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1 .st, l.t.P. 1.no 1.92 2.o• 2.t6 z.~e 2.•o 2·5 
Concentration 
Note: C = commercial acetone standard sampled from the exponential dilution flask, S "' com-
mercial acetone standard sampled from collection bags. If areas for duplicate samples 
are equal at a given time, only one value is printed. There are 22 additional observed 
values hidden. The values in parentheses indicate the number of observations for the 
corresponding log concentration. 
Figure 12. Logarithm of Reported Acetone Peak Area Versus Logarithm of Acetone Concentra-
tion Using Commercial Standard Acetone and Sampling from Collection Bags and 
the Exponential Dilution Flask 
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